Related Experiment Video
Updated: Jun 29, 2026

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival
Elizabeth Yee-Wai Choy1, Kam-Leung Siu, Kin-Hang Kok
1Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong.
Abstract:
Epstein-Barr virus (EBV) is a herpesvirus associated with nasopharyngeal carcinoma (NPC), gastric carcinoma (GC), and other malignancies. EBV is the first human virus found to express microRNAs (miRNAs), the functions of which remain largely unknown. We report on the regulation of a cellular protein named p53 up-regulated modulator of apoptosis (PUMA) by an EBV miRNA known as miR-BART5, which is abundantly expressed in NPC and EBV-GC cells. Modulation of PUMA expression by miR-BART5 and anti-miR-BART5 oligonucleotide was demonstrated in EBV-positive cells. In addition, PUMA was found to be significantly underexpressed in approximately 60% of human NPC tissues. Although expression of miR-BART5 rendered NPC and EBV-GC cells less sensitive to proapoptotic agents, apoptosis can be triggered by depleting miR-BART5 or inducing the expression of PUMA. Collectively, our findings suggest that EBV encodes an miRNA to facilitate the establishment of latent infection by promoting host cell survival.
Insights
Epstein-Barr virus (EBV) microRNA miR-BART5 downregulates the PUMA protein, promoting cancer cell survival. Inhibiting miR-BART5 or boosting PUMA can trigger apoptosis in EBV-associated cancers.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Epstein-Barr virus (EBV) is linked to nasopharyngeal carcinoma (NPC) and gastric carcinoma (GC).
- EBV encodes microRNAs (miRNAs) with largely unknown functions.
- P53 up-regulated modulator of apoptosis (PUMA) is a key regulator of programmed cell death.
Purpose of the Study:
- To investigate the role of EBV-encoded miR-BART5 in regulating PUMA expression.
- To determine the impact of miR-BART5/PUMA modulation on cancer cell apoptosis.
- To explore the therapeutic potential of targeting miR-BART5 in EBV-associated malignancies.
Main Methods:
- Quantitative real-time PCR to measure miR-BART5 and PUMA expression.
- Western blot analysis to assess PUMA protein levels.
- Transfection with miR-BART5 mimics and inhibitors in EBV-positive cancer cells.
- Analysis of PUMA expression in human NPC tissues.
Main Results:
- miR-BART5 directly downregulates PUMA expression in EBV-positive cells.
- PUMA is significantly underexpressed in approximately 60% of NPC tissues.
- miR-BART5 expression reduces cancer cell sensitivity to apoptosis.
- Depleting miR-BART5 or inducing PUMA restores apoptosis in cancer cells.
Conclusions:
- EBV utilizes miR-BART5 to suppress PUMA, thereby promoting host cell survival and facilitating latent infection.
- Targeting miR-BART5 or restoring PUMA expression represents a potential therapeutic strategy for EBV-associated cancers.
- This study elucidates a novel mechanism of viral oncogenesis driven by miRNA-mediated gene silencing.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
MicroRNAs
Inhibitors of Virion Maturation and Assembly
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

